Niagen Bioscience Inc (NAGE) Financials

NAGE Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 106.6 million 24.1 million
March 31, 2026 114.3 million 32.0 million
Dec. 31, 2025 106.4 million 29.9 million
Sept. 30, 2025 98.1 million 27.5 million

NAGE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 2.7 million 1.7 million
March 31, 2026 -1.3 million 1.7 million
Dec. 31, 2025 578000 1.7 million
Sept. 30, 2025 3.7 million 1.8 million

NAGE Net Income

No data available :(

NAGE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 66.7 million - 2.3 million
March 31, 2026 66.5 million - 1.5 million
Dec. 31, 2025 64.8 million - 1.8 million
Sept. 30, 2025 64.1 million - 3.1 million

NAGE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 82.5 million
March 31, 2026 84.6 million
Dec. 31, 2025 84.4 million
Sept. 30, 2025 86.6 million

NAGE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 89000 1.5 million 17.1 million 10.1 million
March 31, 2026 61000 1.5 million 16.9 million 9.7 million
Dec. 31, 2025 101000 1.7 million 17.9 million 10.4 million
Sept. 30, 2025 24000 1.8 million 15.9 million 8.8 million

NAGE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 29.8 million 10.5 million
March 31, 2026 31.5 million 11.5 million
Dec. 31, 2025 33.8 million 12.1 million
Sept. 30, 2025 34.0 million 12.1 million

NAGE

Price: $3.18

52 week price:
2.87
11.29

Earnings Per Share: 0.19 USD

P/E Ratio: 16.05

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 242.9 million

Links: